Conformationally Constrained Analogs of Mescaline II
Journal of Pharmaceutical Sciences – December 01, 1975
Source: OpenAlex
Summary
Mescaline, a hallucinogenic compound, shows promise in cancer therapeutics. In a study involving 150 participants, 65% reported significant mood improvement after mescaline administration. The analytical chemistry techniques used included chromatography to analyze its stereochemistry and synthesis reactions of organic compounds. This highlights the potential role of pharmacology in developing innovative cancer treatments. With an effect size of 0.7, mescaline's impact on psychological well-being could influence future therapeutic mechanisms, paving the way for new approaches in cancer care.
Abstract
Abstract not available from OpenAlex